Translate
Recent News
-
Symposium’23 Program
Program here.
“Innovative drugs & health products,
imaging & theranostics agents –
cell & gene biotherapies”, March 17, 2023, 13:30 -
3e matinée Carnot Star “9-12 Recherche-Industrie” dédiée à l’Imagerie, 17 Mars 2023, 8h30
Programme ici, inscriptions ici, . -
FairEmbo en Afrique : “Ce médecin marseillais sauve des femmes avec des bouts de ficelle”
FairEmbo en Afrique : l’Embolisation-pour-tous franchit une nouvelle étape. Plus d’informations ici. -
Webinar: Discover Radiotheranostics in Nuclear Medicine (15 Sept. 2022)
Plus d’informations ici. -
Le projet EmboBio, développé au CERIMED, a reçu le prix de l’innovation AP-HM 2022
Plus d’informations sur le prix AP-HM de l’innovation 2022 ici. Plus d’informations sur le projet Embobio dans cette vidéo. -
Le CERIMED obtient la double certification ISO 9001:2015 et NF X50-900:2016 pour ses activités de prestation et d’innovation radiologiques et nucléaires pré-cliniques
Le Centre Européen de Recherche en Imagerie Médicale (CERIMED, UMS AMU CNRS 2012) a obtenu le 5 juin 2022 la double certification ISO 9001:2015 et NF-X50-900:2016 pour -
Symposium’21 Program
Program here.
“Innovative drugs & health products,
imaging & theranostics agents –
cell & gene biotherapies” -
VECT-HORUS and CERIMED Announce Collaboration to Support the Development of VECT-HORUS’ Theragnostic Agents
VECT-HORUS, a biotechnology company that designs and develops vectors that facilitate the targeted delivery of therapeutic molecules and imaging agents, has announced the signing of a collaboration -
FAIR-Embo hopes to spread safe, cheap embolization around the world
We are proud to anounce that Pr Vincent Vidal (Marseille, France), Head of the Experimental Interventional Radiology Laboratory hosted at CERIMED, and colleagues have demonstrated the in vivo feasibility
Last Publications (10/481)
- Bobot, M, Placier, S, Samson, C, Prignon, A, Louedec, L, Frère, P et al.. Acute Kidney Injury Induces Neurological Impairment Through Early Blood-Brain Barrier Disruption and Endothelial Transcytosis in Mice. Crit Care Med. 2026; :. doi: 10.1097/CCM.0000000000007285. PubMed PMID:42560137 .
- Long-Depaquit, T, Baboudjian, M, Peyrottes, A, Diamand, R, Ploussard, G. Patient Selection Matters: Who Is Represented in PROTEUS?. Eur Urol Oncol. 2026; :. doi: 10.1016/j.euo.2026.07.006. PubMed PMID:42527284 .
- Alavi, A, Revheim, ME, Newberg, AB, Werner, TJ, Guedj, E. 18F-Fluorodeoxyglucose PET, the Brain, and Other Organs: From the First Human Studies (1976) to 2026. PET Clin. 2026; :. doi: 10.1016/j.cpet.2026.05.001. PubMed PMID:42481350 .
- Berti, V, Fasciglione, E, Charpiot, A, Montanini, F, Pepponi, M, Leo, A et al.. Correction: Deciphering 18F-DOPA uptake in SDH-related head and neck paragangliomas: a radiomics approach. J Endocrinol Invest. 2026; :. doi: 10.1007/s40618-026-02985-2. PubMed PMID:42461578 .
- Sarrade, A, El Allam, J, Espinas, V, Hoffart, L, Picard, C, David, T et al.. Fast and compact scatterometer for ex vivo qualification of low-scattering biological samples. Rev Sci Instrum. 2026;97 (7):. doi: 10.1063/5.0327390. PubMed PMID:42439722 .
- Guedj, E, Beckman, D. Dopaminergic vulnerability in long COVID: striatal PET imaging at the brain-body interface. EBioMedicine. 2026; :106369. doi: 10.1016/j.ebiom.2026.106369. PubMed PMID:42431744 .
- Baboudjian, M, Barret, E, Brureau, L, Fiard, G, Fromont, G, Olivier, J et al.. Evidence thresholds for novel therapeutic strategies in prostate cancer: A consensus statement from the Prostate Cancer Committee of the French Urological Association. Fr J Urol. 2026;36 (9):103162. doi: 10.1016/j.fjurol.2026.103162. PubMed PMID:42413772 .
- Guedj, E, Newberg, AB, Alavi, A. Future Directions for [18F]FDG PET in Central Nervous System Diseases. PET Clin. 2026; :. doi: 10.1016/j.cpet.2026.06.003. PubMed PMID:42409693 .
- Guedj, E, Newberg, AB, Alavi, A. How Fluorine-18-labeled Fluorodeoxyglucose PET Changed Clinical Practice in Central Nervous System Disorders. PET Clin. 2026; :. doi: 10.1016/j.cpet.2026.06.002. PubMed PMID:42409692 .
- Long-Depaquit, T, Baboudjian, M, Peyrottes, A, Uleri, A, Anract, J, Sordelli, F et al.. Transperineal Versus Transrectal Magnetic Resonance Imaging-targeted Prostate Biopsy in the Era of Lesion-focused Sampling. Eur Urol Focus. 2026; :. doi: 10.1016/j.euf.2026.04.016. PubMed PMID:42399176 .
Dernières Publications (10/481)
- Bobot, M, Placier, S, Samson, C, Prignon, A, Louedec, L, Frère, P et al.. Acute Kidney Injury Induces Neurological Impairment Through Early Blood-Brain Barrier Disruption and Endothelial Transcytosis in Mice. Crit Care Med. 2026; :. doi: 10.1097/CCM.0000000000007285. PubMed PMID:42560137 .
- Long-Depaquit, T, Baboudjian, M, Peyrottes, A, Diamand, R, Ploussard, G. Patient Selection Matters: Who Is Represented in PROTEUS?. Eur Urol Oncol. 2026; :. doi: 10.1016/j.euo.2026.07.006. PubMed PMID:42527284 .
- Alavi, A, Revheim, ME, Newberg, AB, Werner, TJ, Guedj, E. 18F-Fluorodeoxyglucose PET, the Brain, and Other Organs: From the First Human Studies (1976) to 2026. PET Clin. 2026; :. doi: 10.1016/j.cpet.2026.05.001. PubMed PMID:42481350 .
- Berti, V, Fasciglione, E, Charpiot, A, Montanini, F, Pepponi, M, Leo, A et al.. Correction: Deciphering 18F-DOPA uptake in SDH-related head and neck paragangliomas: a radiomics approach. J Endocrinol Invest. 2026; :. doi: 10.1007/s40618-026-02985-2. PubMed PMID:42461578 .
- Sarrade, A, El Allam, J, Espinas, V, Hoffart, L, Picard, C, David, T et al.. Fast and compact scatterometer for ex vivo qualification of low-scattering biological samples. Rev Sci Instrum. 2026;97 (7):. doi: 10.1063/5.0327390. PubMed PMID:42439722 .
- Guedj, E, Beckman, D. Dopaminergic vulnerability in long COVID: striatal PET imaging at the brain-body interface. EBioMedicine. 2026; :106369. doi: 10.1016/j.ebiom.2026.106369. PubMed PMID:42431744 .
- Baboudjian, M, Barret, E, Brureau, L, Fiard, G, Fromont, G, Olivier, J et al.. Evidence thresholds for novel therapeutic strategies in prostate cancer: A consensus statement from the Prostate Cancer Committee of the French Urological Association. Fr J Urol. 2026;36 (9):103162. doi: 10.1016/j.fjurol.2026.103162. PubMed PMID:42413772 .
- Guedj, E, Newberg, AB, Alavi, A. Future Directions for [18F]FDG PET in Central Nervous System Diseases. PET Clin. 2026; :. doi: 10.1016/j.cpet.2026.06.003. PubMed PMID:42409693 .
- Guedj, E, Newberg, AB, Alavi, A. How Fluorine-18-labeled Fluorodeoxyglucose PET Changed Clinical Practice in Central Nervous System Disorders. PET Clin. 2026; :. doi: 10.1016/j.cpet.2026.06.002. PubMed PMID:42409692 .
- Long-Depaquit, T, Baboudjian, M, Peyrottes, A, Uleri, A, Anract, J, Sordelli, F et al.. Transperineal Versus Transrectal Magnetic Resonance Imaging-targeted Prostate Biopsy in the Era of Lesion-focused Sampling. Eur Urol Focus. 2026; :. doi: 10.1016/j.euf.2026.04.016. PubMed PMID:42399176 .